Today’s blog post is the third, and last, blog post in a series focusing on trade secret law issues and trends. As announced, we will address practical questions and offer insights into how Belgian courts interpret and apply various aspects of the Belgian Trade Secrets Act[1], particularly as it relates to unlawful use,
IntroductionToday’s blog post is the second blog post in a series focusing on European trade secret law issues and trends. As announced, we will address practical questions and offer insights into how Belgian courts interpret and apply various aspects of the Belgian Trade Secrets Act[1], particularly as it relates to requirements for trade
IntroductionToday’s blog post starts a series focusing on European trade secret law issues. We will focus on practical questions and share insights on how Belgian courts use the Belgian Trade Secrets Act and interpret its rules according to the EU Trade Secrets Directive.[1]
A similar blog series first came out in 2021.[2] Since
A perennial issue in trade secret litigation is: what factual allegations must be pled regarding what trade secrets are left when there are related patents from the same company on the same technology. The recent decision Safe Haven Wildlife Removal and Property Management Experts, LLC v. Meridian Wildlife Services LLC provides insight on this issue
The Ninth Circuit’s decision in Perrin Bernard Supowitz, LLC v. Morales continues to highlight the high bar necessary for a motion for preliminary injunction, the evidence required to establish irreparable harm, and the limited “abuse of discretion” standard that may be applied during any appeal. Case No. 23-55189, 2023 WL 1415572 (9th Cir. Feb. 5
The legal battle between VANDA Pharmaceuticals, Inc. and the United States government provides guidance on the minimum requirements that the government must meet to protect trade secrets provided during the regulatory approval process for pharmaceuticals. The case, which involves alleged unlawful disclosure of trade secrets by government officials to generic drug competitors, presents several issues of
Restrictive covenants and non-compete agreements have been a frequent topic of this blog in recent months, and rightfully so. Non-competes are generally thought to be effective tools to help firms protect trade secrets and competitive advantages. However, these agreements are falling out of favor across the country – the DOJ recently file a Statement of
The California Office of the Attorney General issued its first opinion interpreting the California Consumer Privacy Act (CCPA) on March 10, 2022, addressing the issue of whether a consumer has a right to know the inferences that a business holds about the consumer. The AG concluded that, unless a statutory exception applies, internally generated inferences that
Within the Tenth Circuit, states vary in their enforcement of restrictive covenants. Wyoming, Kansas, and New Mexico govern the use of restrictive covenants through common law while Utah, Colorado, and Oklahoma govern through statute. Oklahoma is unique in that it prohibits restrictive covenants through statute. In the other five states, despite the variations in governing
